8 research outputs found
Relevant Interactions of Antimicrobial Iron Chelators and Membrane Models Revealed by Nuclear Magnetic Resonance and Molecular Dynamics Simulations
The
dynamics and interaction of 3-hydroxy-4-pyridinone fluorescent
iron chelators, exhibiting antimicrobial properties, with biological
membranes were evaluated through NMR and molecular dynamics simulations.
Both NMR and MD simulation results support a strong interaction of
the chelators with the lipid bilayers that seems to be strengthened
for the rhodamine containing compounds, in particular for compounds
that include ethyl groups and a thiourea link. For the latter type
of compounds the interaction reaches the hydrophobic core of the lipid
bilayer. The molecular docking and MD simulations performed for the
potential interaction of the chelators with DC-SIGN receptors provide
valuable information regarding the cellular uptake of these compounds
since the results show that the fluorophore fragment of the molecular
framework is essential for an efficient binding. Putting together
our previous and present results, we put forward the hypothesis that
all the studied fluorescent chelators have access to the cell, their
uptake occurs through different pathways and their permeation properties
correlate with a better access to the cell and its compartments and,
consequently, with the chelators antimicrobial properties
600 MHz <sup>1</sup>H-NMR spectra of: A. DMEM; B. 24 h DMEM; C. 48 H <i>Com. Medium</i>; D. 24 h <i>Com. Medium</i><sup>1</sup>; E. 24 h <i>Com. Medium</i><sup>2</sup>; F. <i>Com. Medium</i>; G. <i>Plasma1</i>; H. <i>Plasma2</i>; I. <i>Plasma3</i>; J. <i>Plasma4</i>; K. <i>Plasma5</i>.
<p>The codes (1-28) represent metabolites from <b><a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0113769#pone.0113769.s006" target="_blank">Table S5</a></b>. *D and E correspond to two different samples with the same basal medium (<i>Com. Medium</i>) and time of conditioning (24 h). <i>Com. Medium is</i> Commercial medium from PromoCell (LabClinics, Promocell, C-28010).</p
600 MHz <sup>1</sup>H/<sup>1</sup>H 2D COSY NMR spectra of <i>48 h Com. Medium</i> sample.
<p><i>Com. Medium is</i> Commercial medium from PromoCell (LabClinics, Promocell, C-28010).</p
Total nucleated cells per liter of umbilical cord blood collected measured (TNC cell x 10<sup>9</sup>/l) obtained by using the hematology autoanalyser (Ac T diff2, Beckman Coulter, Inc.), number of viable CD34<sup>+</sup> cells per ”l of UCB collected (cells/”l), viability of CD34<sup>+</sup> cells (%), number of viable CD45<sup>+</sup> cells per liter of UCB collected (cells Ă10<sup>9</sup>/l) and viability of CD45<sup>+</sup> cells (%) measured by flow citometry of the UCB samples used for <sup>1</sup>H NMR and Multiplexing LASER Bead analysis.
<p>The average and standard deviation (SD) of N â=â 11 is also presented. * Count using the hematology autoanalyser.</p><p>Total nucleated cells per liter of umbilical cord blood collected measured (TNC cell x 10<sup>9</sup>/l) obtained by using the hematology autoanalyser (Ac T diff2, Beckman Coulter, Inc.), number of viable CD34<sup>+</sup> cells per ”l of UCB collected (cells/”l), viability of CD34<sup>+</sup> cells (%), number of viable CD45<sup>+</sup> cells per liter of UCB collected (cells Ă10<sup>9</sup>/l) and viability of CD45<sup>+</sup> cells (%) measured by flow citometry of the UCB samples used for <sup>1</sup>H NMR and Multiplexing LASER Bead analysis.</p
600 MHz <sup>1</sup>H/<sup>1</sup>H 2D TOCSY NMR spectra of <i>48 h Com. Medium</i> sample.
<p><i>Com. Medium is</i> Commercial medium from PromoCell (LabClinics, Promocell, C-28010).</p
600/150 MHz <sup>1</sup>H/<sup>13</sup>C 2D HSQC NMR spectra of <i>48 h Com. Medium</i> sample.
<p><i>Com. Medium is</i> Commercial medium from PromoCell (LabClinics, Promocell, C-28010).</p
Graphical representation of the relative metabolite concentration of the main aminoacids after normalization of the integral signal intensity obtained in the <sup>1</sup>H-NMR spectra of <i>DMEM</i>, <i>24 h DMEM</i>, <i>Com. Medium</i>, <i>24 h</i> and <i>48 h Com.</i>
<p><i>Medium</i> and <i>UCB Plasma</i> (average) samples. Chemical structures of the main metabolites are represented. <i>Com. Medium is</i> Commercial medium from PromoCell (LabClinics, Promocell, C-28010).</p